GlassScriptPhysician profile
Eric F Succar
NPI 1124361621
$14,654.97
in general payments reported to CMS, 2019-2025
19 companies · $4,399 in 2025
The $4,399 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $226 · 2021: $986 · 2022: $1,429 · 2023: $2,040 · 2024: $5,048 · 2025: $4,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,133 · Food and Beverage: $4,341 · Education: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,132.77 |
| Food and Beverage | $4,340.57 |
| Education | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $7,722.00 | 2019-2025 | Dupixent |
| Inspire Medical Systems, INC. | $2,010.44 | 2022-2025 | Inspire |
| Genzyme Corporation | $964.86 | 2022-2025 | |
| Stryker Corporation | $940.79 | 2019-2025 | Audion Et Dilation System, Xpress Ent Dilation System, Medline Industries, INC. |
| Aerin Medical INC. | $865.21 | 2019-2025 | |
| Acclarent, INC | $586.87 | 2019-2024 | Acclarent Navwire |
| Medtronic, INC. | $428.37 | 2021-2024 | Propel, Stealthstation S8 Platform |
| Optinose US, INC. | $284.35 | 2019-2022 | |
| Intersect Ent, INC. | $254.73 | 2019-2021 | |
| Ets Wound Care LLC | $148.63 | 2025 | Mirragen Advanced Wound Matrix |
| Smith+Nephew, INC. | $110.25 | 2019-2024 | Halo |
| Depuy Synthes Sales INC. | $98.21 | 2022 | |
| Integra Lifesciences Corporation | $83.94 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Alk-Abello, INC | $62.24 | 2021 | |
| Glaxosmithkline, LLC. | $31.23 | 2022-2025 | Nucala |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $18.24 | 2023 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Ambu INC. | $16.70 | 2020 | |
| Hikma Pharmaceuticals USA | $14.15 | 2024 | Ryaltris |
| Takeda Pharmaceuticals U.S.A., INC. | $13.76 | 2025 | Eohilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Succar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.